141 related articles for article (PubMed ID: 10086658)
21. Susceptibility of Helicobacter pylori to metronidazole.
Perna F; Gatta L; Figura N; Ricci C; Tampieri A; Holton J; Miglioli M; Vaira D
Am J Gastroenterol; 2003 Oct; 98(10):2157-61. PubMed ID: 14572561
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population.
Storskrubb T; Aro P; Ronkainen J; Wreiber K; Nyhlin H; Bolling-Sternevald E; Talley NJ; Engstrand L; Agréus L
Helicobacter; 2006 Aug; 11(4):224-30. PubMed ID: 16882324
[TBL] [Abstract][Full Text] [Related]
23. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
24. Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
Marko D; Calvet X; Ducons J; Guardiola J; Tito L; Bory F;
Helicobacter; 2005 Feb; 10(1):22-32. PubMed ID: 15691312
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of gastroscopy.
Bytzer P
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):749-60. PubMed ID: 10730568
[TBL] [Abstract][Full Text] [Related]
26. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance.
Graham DY; de Boer WA; Tytgat GN
Am J Gastroenterol; 1996 Jun; 91(6):1072-6. PubMed ID: 8651150
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia.
Makris N; Crott R; Fallone CA; Bardou M; Barkun A
Gastrointest Endosc; 2003 Jul; 58(1):14-22. PubMed ID: 12838214
[TBL] [Abstract][Full Text] [Related]
28. What is the best strategy for diagnosis and treatment of Helicobacter pylori in the prevention of recurrent peptic ulcer bleeding? A cost-effectiveness analysis.
Gené E; Sanchez-Delgado J; Calvet X; Gisbert JP; Azagra R
Value Health; 2009; 12(5):759-62. PubMed ID: 19490560
[TBL] [Abstract][Full Text] [Related]
29. [Antimicrobial resistance testing of H. pylori epsilometer test and disk diffusion test].
Fukazawa K; Seki M; Satoh K; Sugano K
Nihon Rinsho; 1999 Jan; 57(1):76-80. PubMed ID: 10036939
[TBL] [Abstract][Full Text] [Related]
30. Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis.
Marshall JK; Armstrong D; O'Brien BJ
Can J Gastroenterol; 2000 May; 14(5):379-88. PubMed ID: 10851277
[TBL] [Abstract][Full Text] [Related]
31. Culture-guided treatment approach for Helicobacter pylori infection: review of the literature.
Cammarota G; Ianiro G; Bibbò S; Di Rienzo TA; Masucci L; Sanguinetti M; Gasbarrini A
World J Gastroenterol; 2014 May; 20(18):5205-11. PubMed ID: 24833850
[TBL] [Abstract][Full Text] [Related]
32. A growing demand for Helicobacter pylori culture in the near future?
Mégraud F
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):574-6. PubMed ID: 9513836
[TBL] [Abstract][Full Text] [Related]
33. Economics of Helicobacter pylori eradication therapy.
Deltenre MA
Eur J Gastroenterol Hepatol; 1997 Apr; 9 Suppl 1():S23-6; discussion S27-9. PubMed ID: 9160213
[TBL] [Abstract][Full Text] [Related]
34. Managing dyspepsia: what do we know and what do we need to know?
Rabeneck L; Wray NP; Graham DY
Am J Gastroenterol; 1998 Jun; 93(6):920-4. PubMed ID: 9647019
[TBL] [Abstract][Full Text] [Related]
35. Gastric ulcers at endoscopy: brush, biopsy, or both?
Sadowski DC; Rabeneck L
Am J Gastroenterol; 1997 Apr; 92(4):608-13. PubMed ID: 9128308
[TBL] [Abstract][Full Text] [Related]
36. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.
Parsonnet J; Harris RA; Hack HM; Owens DK
Lancet; 1996 Jul; 348(9021):150-4. PubMed ID: 8684154
[TBL] [Abstract][Full Text] [Related]
37. [Study of the cost-effectiveness of sequential antibiotic (ciprofloxacin) therapy].
Ludwig E; Kovács G; Nagy G; Székely E
Orv Hetil; 1997 Nov; 138(48):3043-7. PubMed ID: 9441266
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of dyspepsia and functional gastrointestinal disorders: a cost-benefit analysis of different approaches.
Sonnenberg A; Townsend WF; Müller AD
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):655-9. PubMed ID: 8590161
[TBL] [Abstract][Full Text] [Related]
39. Non-invasive testing for Helicobacter pylori in patients hospitalized with peptic ulcer hemorrhage: a cost-effectiveness analysis.
Atreja A; Fu AZ; Sanaka MR; Vargo JJ
Dig Dis Sci; 2010 May; 55(5):1356-63. PubMed ID: 19582580
[TBL] [Abstract][Full Text] [Related]
40. Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention.
Ma J; Yu M; Shao QQ; Yu XC; Zhang C; Zhao JB; Yuan L; Qi YB; Hu RB; Wei PR; Xiao W; Chen Q; Jia BL; Chen CL; Lu H; Ding SZ
Helicobacter; 2022 Aug; 27(4):e12911. PubMed ID: 35706404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
